Edesa Biotech (EDSA) Cash & Equivalents (2013 - 2026)
Edesa Biotech (EDSA) posted Cash & Equivalents of $10.33 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 16.4% from $12.36 million a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Edesa Biotech's Cash & Equivalents came in at $10.79 million, up 940.4% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 8.4% (FY2020 to FY2025).
- In prior fiscal years, Edesa Biotech's Cash & Equivalents was $1.04 million in FY2024 (-80.7%), $5.36 million in FY2023 (-24.4%), $7.09 million in FY2022 (-9.5%) and $7.84 million in FY2021 (+8.7%).
- The fiscal Q3 2026 figure stands as the lowest quarterly Cash & Equivalents since fiscal Q1 2025.
- On a year-over-year basis, Cash & Equivalents increased in four of the last seven quarters, with growth averaging 336.1%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was fiscal Q4 2025, with growth of 940.4%; the weakest was fiscal Q4 2024, with a decline of 80.7%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Edesa Biotech | 26.68 Mn | -18.85 Mn | - | 10.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.33 Mn |
| Dec 31, 2025 | 12.05 Mn |
| Sep 30, 2025 | 10.79 Mn |
| Jun 30, 2025 | 12.36 Mn |
| Mar 31, 2025 | 13.90 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Mar 31, 2024 | 2.80 Mn |
| Dec 31, 2023 | 4.27 Mn |
| Sep 30, 2023 | 5.36 Mn |
| Jun 30, 2023 | 6.46 Mn |
| Mar 31, 2023 | 7.47 Mn |
| Dec 31, 2022 | 8.27 Mn |
| Sep 30, 2022 | 7.09 Mn |
| Jun 30, 2022 | 12.81 Mn |
| Mar 31, 2022 | 15.89 Mn |
| Dec 31, 2021 | 5.88 Mn |
| Sep 30, 2021 | 7.84 Mn |
| Jun 30, 2021 | 8.05 Mn |
API Access
Edesa Biotech Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();